Angiogenesis as a potential target of pharmaconutrients in cancer therapy

Virginie Granci1, Yves M Dupertuis, Claude Pichard

  • 1Clinical Nutrition, Geneva University Hospital, Geneva, Switzerland.

Abstract

Insights

Pharmaconutrients, derived from natural sources, show promise in inhibiting tumor angiogenesis, a critical process for cancer growth. This review explores their potential in cancer treatment by blocking new blood vessel formation.

Area of Science:

  • Oncology
  • Nutritional Science
  • Pharmacology

Background:

  • Tumor growth relies on angiogenesis, the formation of new blood vessels, to supply oxygen and nutrients.
  • Epidemiological studies suggest dietary factors influence cancer incidence.
  • Pharmaconutrients are natural compounds with potential antitumor effects, offering a safer alternative to conventional therapies.

Purpose of the Study:

  • To review recent findings on tumor angiogenesis inhibition by pharmaconutrients.
  • To highlight the antiangiogenic role of natural products in cancer treatment.
  • To explore the impact of specific nutrients on vascular networks and tumor growth.

Main Methods:

  • Literature review of recent cancer research publications.
  • Focus on studies investigating natural compounds and their antiangiogenic properties.
  • Analysis of pharmaconutrients used alone or in combination with chemotherapy.

Main Results:

  • Pharmaconutrients exhibit anti-tumor activities in various cancer types.
  • Natural products can inhibit tumor angiogenesis by modulating signaling pathways.
  • Dietary nutrients play a role in cancer development by influencing vascular networks.

Conclusions:

  • Natural diets significantly impact cancer development through signaling pathway modulation.
  • Specific nutrients are key in inhibiting tumor angiogenesis by affecting vascular networks.
  • Pharmaconutrients represent a promising strategy for cancer treatment by targeting angiogenesis.

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...